3,6-ketal and enol ether macrolide antibiotics
    1.
    发明授权
    3,6-ketal and enol ether macrolide antibiotics 失效
    3,6-缩酮和烯醇醚大环内酯类抗生素

    公开(公告)号:US6043226A

    公开(公告)日:2000-03-28

    申请号:US257709

    申请日:1999-02-25

    CPC分类号: C07H17/08

    摘要: This invention relates to compounds of formulas 1 and 2 ##STR1## and to pharmaceutically acceptable salts and solvates thereof, wherein X, X.sup.1, R.sup.1, R.sup.2, R.sup.7, R.sup.17 and R.sup.19 are as defined herein. The compounds of formulas 1 and 2 may be useful in the treatment of bacterial, parasitic and protozoal infections, as well as disorders related to bacterial, parasitic and protozoal infections, in mammals, fish and birds. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and 2 and to methods of treating bacterial, parasitic and protozoal infections by administering the compounds of formula 1 and 2.

    摘要翻译: 本发明涉及式1和式2的化合物及其药学上可接受的盐和溶剂合物,其中X,X 1,R 1,R 2,R 7,R 17和R 19如本文所定义。 式1和2的化合物可用于治疗细菌,寄生虫和原生动物感染以及与哺乳动物,鱼和鸟类中的细菌,寄生虫和原生动物感染有关的疾病。 本发明还涉及含有式1和2化合物的药物组合物以及通过施用式1和式2化合物来治疗细菌,寄生虫和原生动物感染的方法。

    C11 carbamates of macrolide antibacterials
    5.
    发明授权
    C11 carbamates of macrolide antibacterials 失效
    C11大环内酯类抗生素的氨基甲酸酯

    公开(公告)号:US6043227A

    公开(公告)日:2000-03-28

    申请号:US320352

    申请日:1999-05-26

    IPC分类号: C07H17/08 A61K31/70

    CPC分类号: C07H17/08 Y02P20/55

    摘要: This invention relates to compounds of the formula ##STR1## and to pharmaceutically acceptable salts thereof. The compounds of formula 1 are potent antibacterial agents that may be used to treat various bacterial infections and disorders related to such infections. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and to methods of treating bacterial infections by administering the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1 and to intermediates useful in such preparation.

    摘要翻译: 本发明涉及式的化合物及其药学上可接受的盐。 式1的化合物是可用于治疗各种细菌感染和与这种感染有关的疾病的有效的抗菌剂。 本发明还涉及含有式1化合物的药物组合物和通过施用式1化合物治疗细菌感染的方法。本发明还涉及制备式1化合物的方法和用于此类制备的中间体。